TR201914043A1 - Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari - Google Patents

Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari

Info

Publication number
TR201914043A1
TR201914043A1 TR2019/14043A TR201914043A TR201914043A1 TR 201914043 A1 TR201914043 A1 TR 201914043A1 TR 2019/14043 A TR2019/14043 A TR 2019/14043A TR 201914043 A TR201914043 A TR 201914043A TR 201914043 A1 TR201914043 A1 TR 201914043A1
Authority
TR
Turkey
Prior art keywords
metformin
efervesan
dapaglyflozin
tablet formulations
formulations containing
Prior art date
Application number
TR2019/14043A
Other languages
English (en)
Inventor
Ulusoy Bozyel Müge
Dedeoğlu Yavuz
Taşkin Abdullah
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2019/14043A priority Critical patent/TR201914043A1/tr
Priority to EP20866500.0A priority patent/EP4031122A4/en
Priority to PCT/TR2020/050687 priority patent/WO2021054912A1/en
Publication of TR201914043A1 publication Critical patent/TR201914043A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Buluş, dapagliflozin veya dapagliflozinin farmasötik olarak kabul edilebilir bir tuzu ve metformin veya metforminin farmasötik olarak kabul edilebilir bir tuzu ile gerçekleştirilen efervesan tablet formülasyonlar ile ilgilidir.
TR2019/14043A 2019-09-16 2019-09-16 Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari TR201914043A1 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2019/14043A TR201914043A1 (tr) 2019-09-16 2019-09-16 Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari
EP20866500.0A EP4031122A4 (en) 2019-09-16 2020-08-05 Effervescent TABLET FORMULATIONS WITH DAPAGLIFLOZINE AND METFORMIN
PCT/TR2020/050687 WO2021054912A1 (en) 2019-09-16 2020-08-05 Effervescent tablet formulations comprising dapagliflozin and metformin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/14043A TR201914043A1 (tr) 2019-09-16 2019-09-16 Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari

Publications (1)

Publication Number Publication Date
TR201914043A1 true TR201914043A1 (tr) 2021-04-21

Family

ID=74883168

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/14043A TR201914043A1 (tr) 2019-09-16 2019-09-16 Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari

Country Status (3)

Country Link
EP (1) EP4031122A4 (tr)
TR (1) TR201914043A1 (tr)
WO (1) WO2021054912A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
EP4079296A1 (en) * 2021-04-21 2022-10-26 Sanovel Ilac Sanayi Ve Ticaret A.S. A bilayer tablet formulation comprising amorphous dapagliflozin and metformin
CN118078745B (zh) * 2024-04-07 2025-01-24 安徽新世纪药业有限公司 一种盐酸二甲双胍口服溶液的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038979A1 (en) * 2005-09-22 2007-04-12 Swissco Development Ag Effervescent metformin composition and tablets and granules made therefrom
EP3315124B1 (en) * 2009-11-13 2021-01-06 Astrazeneca AB Bilayer tablet formulations
EP2809311A1 (en) * 2012-01-31 2014-12-10 Mahmut Bilgic Effervescent tablet formulations comprising the combination of voglibose and metformin
WO2017098481A1 (en) * 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
WO2018185669A1 (en) * 2017-04-07 2018-10-11 Zenvision Pharma Llp Effervescent compositions comprising saxagliptin or salt thereof

Also Published As

Publication number Publication date
WO2021054912A1 (en) 2021-03-25
EP4031122A4 (en) 2023-08-30
EP4031122A1 (en) 2022-07-27

Similar Documents

Publication Publication Date Title
JOP20220008A1 (ar) مثبطات parp1
TR201916829A2 (tr) Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari
MX2023013096A (es) Uso farmaceutico de compuesto de peptidos ciclicos.
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
PH12022551226A1 (en) Pyrrolotriazine compounds acting as mnk inhibitor
PH12019550249A1 (en) Solid compositions for oral administration
TN2017000495A1 (en) Notch pathway signaling inhibitor compounds.
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
TR201914043A1 (tr) Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari
EA202090542A1 (ru) Высококонцентрированные лекарственные формы придопидина
CL2020002199A1 (es) Compuesto de anillo de metillactama y uso farmacéutico del mismo.
MX2020005483A (es) Antagonistas de ildr2 y combinaciones de los mismos.
PH12020551985A1 (en) Anti-human tlr7 antibody
GEP20237486B (en) Formulations of copanlisib
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
TR201722367A2 (tr) Lakozami̇d i̇çeren parenteral uygulmaya yöneli̇k farmasöti̇k kompozi̇syonlar
TR201713954A2 (tr) Tenofovir, emtrisitabin ve efavirenzin farmasötik kombinasyonlari
TR201913472A2 (tr) Vi̇ldagli̇pti̇n ve metformi̇n i̇çeren bi̇r kombi̇nasyon
EA201890929A1 (ru) Низкие дозировки композиций дипиридамола для перорального приема и их использование
TR201914406A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r farmasöti̇k eksi̇pi̇yan i̇çeren kati oral farmasöti̇k formülasyonlar
TR201914416A1 (tr) Sapropteri̇n di̇hi̇droklorürün efervesan formülasyonlari
TR201914420A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar
BR112022012584A2 (pt) Compostos e derivados de hidroxiestilbeno substituído, síntese e uso deles
TR202010528A2 (tr) Oksi̇dati̇f stresi̇n azaltilmasi i̇çi̇n bi̇r bi̇leşi̇k
JOP20200005A1 (ar) تركيبات صيدلية